Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. (Q30308044)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. |
scientific article |
Statements
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes (English)
Slingluff CL Jr
Yamshchikov G
Neese P
Galavotti H
Eastham S
Kittlesen D
Deacon D
Hibbitts S
Grosh WW
Petroni G
Cohen R
Wiernasz C
Patterson JW
Conway BP
1 October 2001